CA2723704C - Nitric oxide donating prostamides - Google Patents

Nitric oxide donating prostamides Download PDF

Info

Publication number
CA2723704C
CA2723704C CA2723704A CA2723704A CA2723704C CA 2723704 C CA2723704 C CA 2723704C CA 2723704 A CA2723704 A CA 2723704A CA 2723704 A CA2723704 A CA 2723704A CA 2723704 C CA2723704 C CA 2723704C
Authority
CA
Canada
Prior art keywords
ono2
independently selected
alkenyl
alkynyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2723704A
Other languages
English (en)
French (fr)
Other versions
CA2723704A1 (en
Inventor
Francesca Benedini
Stefano Biondi
Valerio Chiroli
Wesley Kwan Mung Chong
Liming Dong
Achim Hans-Peter Krauss
Fabio Nicoli
Ganesh Prasanna
William Francois Vernier
Yi Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Publication of CA2723704A1 publication Critical patent/CA2723704A1/en
Application granted granted Critical
Publication of CA2723704C publication Critical patent/CA2723704C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA2723704A 2008-05-09 2009-05-11 Nitric oxide donating prostamides Active CA2723704C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US61/052,084 2008-05-09
US13933308P 2008-12-19 2008-12-19
US61/139,333 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (2)

Publication Number Publication Date
CA2723704A1 CA2723704A1 (en) 2009-11-12
CA2723704C true CA2723704C (en) 2017-08-22

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2723704A Active CA2723704C (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Country Status (8)

Country Link
US (1) US8101658B2 (https=)
EP (1) EP2274279B1 (https=)
JP (1) JP5401540B2 (https=)
CN (1) CN102099330B (https=)
AR (1) AR076731A1 (https=)
CA (1) CA2723704C (https=)
ES (1) ES2428387T3 (https=)
WO (1) WO2009136281A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6087147B2 (ja) * 2009-06-22 2017-03-01 ジョンソン、マッセイ、パブリック、リミテッド、カンパニーＪｏｈｎｓｏｎ Ｍａｔｔｈｅｙ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ プロスタグランジンの精製方法
BR112013020719B1 (pt) 2011-02-14 2018-04-17 Allergan, Inc. Composições de derivados de bimatoprost tipo éster e métodos
US20150174158A1 (en) 2012-03-07 2015-06-25 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
ES2609810T3 (es) 2012-05-31 2017-04-24 Theravance Biopharma R&D Ip, Llc Inhibidores de neprilisina donadores de óxido nítrico
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
US10280138B2 (en) 2015-03-31 2019-05-07 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
AU2016320638B2 (en) 2015-09-09 2019-12-19 Beyond Air Ltd Nitric oxide inhalation therapy for infants with bronchiolitis
MX2019005321A (es) 2016-11-08 2019-10-14 Bausch & Lomb Derivados de prostaglandina que liberan oxido nitrico para el tratamiento de glaucoma de tension normal.
PT3530649T (pt) * 2018-02-21 2020-12-04 Nicox Sa Processo para a preparação de um análogo de prostaglandina que doa óxido nítrico
RU2718744C2 (ru) 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
EP3718535B1 (en) 2018-07-12 2025-06-18 Nicox S.A. Ophthalmic compositions containing a nitric oxide releasing prostamide
EP3772511B1 (en) * 2019-08-05 2023-11-08 Nicox S.A. Process for the preparation of a nitric oxide donating prostaglandin analogue
ES3017242T3 (en) 2021-02-03 2025-05-12 Nicox Sa Process for the preparation of a nitric oxide donating prostaglandin analogue
EP4404936A1 (en) 2021-09-20 2024-07-31 Nicox SA Nitric oxide releasing prostamide as neuroprotective agent
CN119350280A (zh) * 2021-11-18 2025-01-24 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
LT4303211T (lt) 2022-07-07 2024-11-25 Nicox S.A. Pramoninis procesas, skirtas heksano rūgšties, 6-(nitrooksi)-, (1s,2e)-3- [(1r,2r,3s,5r)-2-[(2z)-7-(etilamino)-7-okso-2-hepten-1-il]-3,5- dihidroksiciklopentil]-1-(2-feniletil)-2-propen-1-ilo esterio ir aukšto grynumo produkto gamybai
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药（常熟）有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
JP2005519115A (ja) * 2002-03-01 2005-06-30 アラーガン、インコーポレイテッド プロスタミドの製造
MXPA06007678A (es) * 2004-01-05 2006-09-01 Nicox Sa Nitroxiderivados de prostaglandinas.
JP2009501150A (ja) * 2005-06-29 2009-01-15 ファイザー・インク プロスタグランジン誘導体
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
CN102099330A (zh) 2011-06-15
US8101658B2 (en) 2012-01-24
CN102099330B (zh) 2014-04-30
EP2274279B1 (en) 2013-07-31
ES2428387T3 (es) 2013-11-07
WO2009136281A1 (en) 2009-11-12
EP2274279A1 (en) 2011-01-19
JP5401540B2 (ja) 2014-01-29
US20110092590A1 (en) 2011-04-21
HK1160835A1 (en) 2012-08-17
JP2011519910A (ja) 2011-07-14
AR076731A1 (es) 2011-07-06
CA2723704A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
CA2723704C (en) Nitric oxide donating prostamides
US12180248B2 (en) Compositions and methods for treating CNS disorders
DE69512891T2 (de) Metalloproteinaseinhibitoren
AU2004313688B2 (en) Prostaglandin nitrooxyderivatives
CA3103711A1 (en) Spirocyclic indane analogues as il-17 modulators
DE69615058T2 (de) Metalloproteinase inhibitoren
BR112020000863A2 (pt) Inibidores de magl
CA3064156A1 (en) Spirocyclic indolines as il-17 modulators
EP0997147A1 (en) Amino acid derivatives
JP2018076234A (ja) ピラゾロ［１，５−ａ］ピリミジン化合物
BG64213B1 (bg) Глюкокортикоидселективни противовъзпалителни средства
CN107021887A (zh) 四环素类化合物
CS172591A3 (en) Radicicol derivatives, process of their preparation and use
CN119110795A (zh) 用于治疗与lpa受体活性相关的病症的化合物和组合物
JP2009500315A (ja) フルオロプロスタグランジンのニトロ誘導体
WO2018089402A1 (en) Tricyclic sulfones as ror gamma modulators
BR112021007041A2 (pt) composto e composição farmacêutica
DE2337630A1 (de) Neue in 15-stellung substituierte prostansaeuren und ester davon, sowie verfahren zu ihrer herstellung
HK1160835B (en) Nitric oxide donating prostamides
CA2460358A1 (en) Hydroxyfattysulfonic acid analogs
JPWO2008146917A1 (ja) リンコマイシン誘導体及びこれを有効成分とする抗菌剤
JP2005120070A (ja) エラスターゼ遊離抑制剤及び脳梗塞治療薬
EP0432974A1 (en) Cyclic renin inhibitors
EP0432975A1 (en) Cyclic renin inhibitors
CN116669721B (zh) 抗胆碱能药物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140429

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250423

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250423